Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2011)
Assembly Biosciences (ASMB) posted quarterly Interest Coverage Ratio of 1.15 for Q4 2025, up 2210.45% year-over-year from 0.05 in Q4 2024, and up 2210.45% quarter-over-quarter from 0.05 in Q4 2024.
Analysis
Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2011) Analysis & Trends
Assembly Biosciences' Interest Coverage Ratio history runs 14 years deep, the most recent figure standing at 1.15 for Q4 2025.
- In Q4 2025, Interest Coverage Ratio rose 2210.45% year-over-year to 1.15; the TTM figure through Dec 2025 stood at 0.7 (down 227.96% YoY), while the FY2025 annual figure was 0.7, down 227.96% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 1.15, up from 0.05 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 1.15 in Q4 2025, with the low at 23401.0 in Q3 2022.
- The 5-year median for Interest Coverage Ratio is 23.11 (2021), against an average of 2221.27.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio sank 1000904.9% in 2022, then jumped 2210.45% in 2025.
- Assembly Biosciences' Interest Coverage Ratio stood at 67.62 in 2021, then soared by 75.23% to 16.75 in 2022, then plunged by 3844.27% to 660.58 in 2023, then jumped by 99.99% to 0.05 in 2024, then surged by 2210.45% to 1.15 in 2025.
- Business Quant data shows ASMB's Interest Coverage Ratio at 1.15 in Q4 2025, 0.05 in Q4 2024, and 660.58 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Assembly Biosciences | 689.29 Mn | 368.93 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | 62.47 |
| Sep 30, 2011 | -19.53 |
| Jun 30, 2011 | -104.72 |
| Mar 31, 2011 | -59.71 |
| Sep 30, 2010 | -0.40 |
| Jun 30, 2010 | -0.96 |